Global Cancer Monoclonal Antibodies Market
Global Cancer Monoclonal Antibodies Markets, 2016-2021, 2021-2026F, 2031F: Bevacizumab (Avastin); Rituximab (Rituxan); Trastuzumab (Herceptin); Cetuximab (Erbitux); Panitumumab (Vectibix)
June 20, 2022 04:23 ET | Research and Markets
Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Global Market Report 2022: By Monoclonal, By Application, By End-User" report has been added to ResearchAndMarkets.com's...
Global Conjugated Monoclonal Antibodies Market
Global Conjugated Monoclonal Antibodies Markets, 2016-2021, 2021-2026F, 2031F by Drugs (Adcetris; Kadcyla) & Technology (Cleavable Linker; Non-cleavable Linker)
June 20, 2022 04:18 ET | Research and Markets
Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Conjugated Monoclonal Antibodies Global Market Report 2022: By Drugs, By Technology, By Application" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Cancer Monoclonal Antibody Partnering Deal Terms and Agreements 2015-2022: Latest Agreements in Monoclonal Antibodies, Murine mAb, Chimeric mAb, Humanized mAb, Human aAb
June 14, 2022 04:33 ET | Research and Markets
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2015-2022" report has been added to ResearchAndMarkets.com's offering. The Cancer...
22157.jpg
Outlook on the Lung Cancer Antibodies Global Market to 2028 - Commercial Information Including Patent, Price, Dosage and Sales Analysis
June 10, 2022 06:18 ET | Research and Markets
Dublin, June 10, 2022 (GLOBE NEWSWIRE) -- The "Global Lung Cancer Antibodies Market, Drug Sales & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Global Immuno-Oncology Diagnostics Market Research Report 2022-2026: Diagnostics Plays New Key Role in Therapeutic Development and Clinical Trials
June 08, 2022 03:53 ET | Research and Markets
Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics, Including Executive/Consultant Guides and Customized Forecasting/Analysis 2022 - 2026" report has...
22157.jpg
3D Cell Culture Markets, 2035
June 07, 2022 06:08 ET | Research and Markets
Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "3D Cell Culture Market by Scaffold Format, Products, Application Areas, Purpose, and Key Geographical Regions: Industry Trends and Global Forecasts,...
22157.jpg
Global Single-Use Upstream Bioprocessing Technology/Equipment Market Trends and Forecasts 2022-2035 with Detailed Interviews with Christopher Brau & Nico Oosterhuis
June 07, 2022 05:58 ET | Research and Markets
Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "Single-Use Upstream Bioprocessing Technology/Equipment Market by Type of Product, Scale of Operation and Key Geographical Regions: Industry Trends and...
22157.jpg
Cytokine Release Syndrome Market Insight, Epidemiology and Market Forecasts, 2022-2032 with Focus on United States, Germany, Spain, Italy, France, United Kingdom and Japan
June 07, 2022 04:28 ET | Research and Markets
Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "Cytokine Release Syndrome - Market Insight, Epidemiology and Market Forecast -2032" report has been added to ResearchAndMarkets.com's offering. This...
22157.jpg
Insights on the Single-Use Downstream Bioprocessing Technology Global Market to 2035 - Industry Trends and Forecasts
June 02, 2022 05:58 ET | Research and Markets
Dublin, June 02, 2022 (GLOBE NEWSWIRE) -- The "Single-Use Downstream Bioprocessing Technology Market by Type of Product, Scale of Operation and Key Geographical Regions, 2022-2035" report has been...
Global Biosimilar Monoclonal Antibodies Market
Global Biosimilar Monoclonal Antibodies Market Report 2022: Market is Expected to Reach $10.64 Billion in 2026 at a CAGR of 18.1% - Long-term Forecast to 2031
June 01, 2022 05:13 ET | Research and Markets
Dublin, June 01, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Monoclonal Antibodies Global Market Report 2022: By Type, By Application, By Compound" report has been added to ResearchAndMarkets.com's...